[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100581718":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":32,"centralContacts":36,"locations":43,"responsibleParty":65,"collaborators":41,"id":68,"slug":41,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":41,"eligibilityCriteria":73,"healthyVolunteers":69,"sex":74,"minAge":75,"maxAge":76,"enrollmentInfo":77,"targetDuration":41,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":41,"overallStatus":46,"whyStopped":41,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Ain Shams University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"ACEIs","ACTIVE_COMPARATOR","0.3 mg\u002Fkg\u002Fdose every 8 hours orally by either a caregiver or caring nurse.",[13],"Drug: ACE Inhibitors",{"label":15,"type":10,"description":16,"interventionNames":17},"β-blockers","0.05 mg\u002Fkg\u002Fdose every 12 hours orally by either a caregiver or caring nurse",[18],"Drug: β -Blockers",[20,26],{"type":21,"name":22,"description":11,"armGroupLabels":23,"otherNames":24},"DRUG","ACE Inhibitors",[9],[25],"Captopril",{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"β -Blockers","0.05 mg\u002Fkg\u002Fdose every 12 hours orally by either a caregiver or caring nurse.",[15],[31],"Carvedilol",[33],{"name":34,"affiliation":5,"role":35},"Manal Hamed El-Hamamsy, Prof","PRINCIPAL_INVESTIGATOR",[37],{"name":38,"role":39,"phone":40,"phoneExt":41,"email":42},"Christen Said","CONTACT","+201093942389",null,"keristin.nazir21@pharma.asu.edu.eg",[44,61],{"facility":45,"status":46,"city":47,"state":41,"zip":48,"country":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"Faculty of Pharmacy, Ain Shams University","RECRUITING","Cairo","11566","Egypt",{"type":51,"coordinates":52},"Point",[53,54],31.24967,30.06263,{"lat":54,"lon":53},[57],{"name":58,"role":39,"phone":59,"phoneExt":41,"email":60},"Aml Elkhouly, Assoc. Prof","0201060355448","Amal.Elkhouly@pharma.asu.edu.eg",{"facility":45,"status":46,"city":47,"state":41,"zip":41,"country":49,"cosmosGeoPoint":62,"geoPoint":64,"contacts":41},{"type":51,"coordinates":63},[53,54],{"lat":54,"lon":53},{"type":35,"investigatorFullName":66,"investigatorTitle":67,"investigatorAffiliation":5,"oldNameTitle":41,"oldOrganization":41},"keristin nazir","Teaching Assistant","100581718",false,"NCT06853951","Cardioprotection on Chemotherapy-Induced Cardiotoxicity","The Effect of Cardioprotective Medications on Chemotherapy-Induced Cardiotoxicity in Childhood Acute Leukemia","Inclusion Criteria:\n\n* Willingness of the legal representative of research participant to participate in the study by giving \"informed consent.\"\n* Ability to take oral medication.\n* Age 2-18 years at the time of diagnosis.\n\nExclusion Criteria:\n\n* Documented allergy to cardioprotective medications","ALL","1 Year","18 Years",{"count":78,"type":79},30,"ESTIMATED","INTERVENTIONAL",[82],"PHASE3","The aim of the present study is to evaluate the protective impact of cardioprotective medications on the chemotherapy- induced cardiotoxicity.",[85],"Cardiotoxicity","2025-02-25",{"date":88,"type":89},"2025-03-03","ACTUAL",{"date":91,"type":89},"2023-07-18",{"date":93,"type":79},"2025-07-18",{"name":5,"class":6},2]